XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Robinhood to Launch Crypto Perpetual Futures in the US
The announcement positions Robinhood as one of the few retail-facing US platforms preparing to offer perpetual futures domestically. Access will be limited to e...
Bitcoin Fails to Hold $85,000 After August PCE Data
Bitcoin pushed above $85,000 following the release of the August Personal Consumption Expenditures (PCE) report from the U. S.
Robinhood Unveils AI Trading Agents and Crypto Perpetuals
Robinhood has unveiled two new product offerings targeted at active traders: AI-powered trading agents and crypto perpetuals contracts. The dual announcement po...
Stablecoin Card Spending Hits Record $1.17B in September
Stablecoin card spending hit a record $1. 17 billion in September, according to Paymentscan data, marking the highest monthly total the payments analytics platf...
Bitcoin Tops $85,000 as U.S. Core PCE Rises 0.2%
The BEA’s Personal Income and Outlays report for August showed core PCE rising 0. 2% month over month , described as cooler than some market expectations headin...
Bitcoin’s $87,000 Rally: Short Squeeze Gives Way to Long Risk
When Bitcoin cleared $85,000 on September 21 , more than $648 million in short positions were liquidated in a single session. Forced buyers — traders whose shor...
